Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reaction
Australian Agency urges caution over Paroxetine during pregnancy
October 13th, 2005
Australia's medicines watchdog, the Therapeutic Goods Administration (TGA), has advised pregnant women who are taking the antidepressant, Paroxetine, to discuss this treatment with their doctor, following some new information from overseas that suggests there may be a slight increased risk to their babies. Preliminary analysis of data from a large study conducted in the United States suggests that there may be an increased risk of birth defects and cardiovascular malformation in babies whose mothers are taking Paroxetine. Australia's chief medical officer, Professor John Horvath, has cautioned pregnant women not to suddenly discontinue using the...
Source: Women's Health Weekly (2005-10-13)
|
